REGULATED DRUG DELIVERY SYSTEM

• US 20100121314A1
• Filed: 10/08/2007
• Published: 05/13/2010
• Est. Priority Date: 10/12/2006
• Status: Abandoned Application

• Current Assignee: Mario Iobbi
• Original Assignee: Mario Iobbi
• Inventors: Iobbi, Mario
• Application Number:
  US12/444,836
• Publication Number:
  US 20100121314A1
• Time in Patent Office: Days
• US Class Current: 604/890.100
• CPC Class Codes: A61M 16/00 Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes stimulating the respiratory movement by mechanical, pneumatic or electrical means, iron lungs combined with gas breathing means A61H31/00
• CPC Class Codes: A61M 16/0051 with alarm devices
• CPC Class Codes: A61M 16/026 specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis
• CPC Class Codes: A61M 16/0677 Gas-saving devices therefor
• CPC Class Codes: A61M 16/101 using an oxygen concentrator
• CPC Class Codes: A61M 16/204 used for inhalation control
• CPC Class Codes: A61M 2005/14208 with a programmable infusion control system, characterised by the infusion program
• CPC Class Codes: A61M 2016/0039 in the inspiratory circuit
• CPC Class Codes: A61M 2205/3553 remote, e.g. between patient's home and doctor's office
• CPC Class Codes: A61M 2205/3584 using modem, internet or bluetooth
• CPC Class Codes: A61M 2205/505 Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
• CPC Class Codes: A61M 2230/06 Heartbeat rate only
• CPC Class Codes: A61M 2230/201 Glucose concentration
• CPC Class Codes: A61M 2230/202 partial carbon oxide pressure, e.g. partial dioxide pressure (P-CO2)
• CPC Class Codes: A61M 2230/205 partial oxygen pressure (P-O2)
• CPC Class Codes: A61M 2230/30 Blood pressure A61M2230/04 takes precedence
• CPC Class Codes: A61M 5/1723 using feedback of body parameters, e.g. blood-sugar, pressure measurement of body parameters A61B5/00

Abstract

A drug delivery device for regulating delivery of a drug to a patient (105) provides a controlled rate of delivery which accounts for changes in health or required dose and, in systems with inherent lag, enables a rapid and accurate response whilst maintaining system stability. The device comprises a drug delivery or dose regulator (103); a sensor (107) for measuring a biochemical or physiological property associated with the drug or the condition to be treated; and a controller (109) configured to control the rate of delivery or dose of drug via the regulator in response to the difference in a measured biochemical or physiological property with respect to a target. In order to maintain the system stability, the controller comprises an anti-wind up component (225) for minimizing wind up effects, and/or a filter sub-component (231) to ensure that the controller does not generate output signals to control the regulator in response to noise or erroneous signals.

Claims

1. A drug delivery device for regulating delivery of a drug to a patient, the device comprising:

a regulator for controllably varying the rate of delivery or dose of a drug passing to the patient;

at least one sensor for measuring a biochemical, biological or physiological property of the patient, said property being associated with the drug to be delivered or with a condition to be treated by the drug to be delivered, and generating a signal corresponding to said measured property;

a controller, in communication with the at least one sensor and the regulator, configured to control the rate of delivery or dose of the drug provided by the regulator in response to one or more measured biochemical, biological or physiological properties provided by the at least one sensor with respect to a target,

the controller comprising

a comparator having a signal input configured to receive an input signal from at least one sensor and being capable of generating an error signal corresponding to the disparity between a target value and an input signal;

an active control component for generating an active output signal in response to the error signal; and

a manipulation component for manipulating the active output signal and generating a post-manipulation signal for communication to the regulator as a final output signal,

characterized in that;

the controller further comprises an anti-wind up component for reducing or inhibiting the effect of signal wind up in the active control component; and

/or

the manipulation component comprises a filter sub-component for conditioning the active output signal,

whereby the final output signal provides a controlled rate of delivery or dosage administered to a patient in response to the measured property.

2. A device as claimed in claim 1, wherein the biochemical, biological or physiological property being measured by the at least one sensor is time-lagged or time-delayed with respect to the delivery or dose of drug with which it is associated.

3. A device as claimed in claim 1, wherein the anti-wind up component comprises a signal disparity component, which generates an anti-wind up signal from the difference between a pre-manipulation signal and a post-manipulation signal, and, optionally, a signal gain for generating an amplified anti-wind up signal, which may be fed into the active control component.

4. A device as claimed in claim 1, wherein the active control component of the controller comprises a proportionally responsive sub-component for providing a proportional response to the error signal and an integrally responsive sub-component for providing an integral response to the error signal, which active control component generates an active output signal corresponding a combination of the responses provided by the sub-components of the active component and wherein the controller further comprises an error signal tuner, which comprises a proportional gain to generate an amplified proportional signal, and an integral gain to generate a pre-integration signal.

5. A device as claimed in claim 3, wherein the active control component further comprises a differentially responsive sub-component for providing a differential response to the error signal and wherein the error signal tuner further comprises a differential gain to generate an amplified pre-differentiation signal.

6. A device as claimed in claim 1, wherein the controller comprises an anti-wind up component as defined in claim 1.

7. A device as claimed in claim 1, wherein the manipulation component comprises one or more of

a saturation (or limit) sub-component for adjusting the active output signal or pre-saturation signal to generate a post-saturation signal falling within predetermined limits;

a filter sub-component for conditioning the active output signal or a post-manipulation signal; and

a phase compensator, for compensating for signal phase lag generated within the system,

one or more of which sub-components are located within the anti-wind up component, whereby the disparity component generates the anti-wind up signal from the difference between a signal before the one or more sub-components and a signal after the one or more sub-components.

8. A device as claimed in claim 7, wherein the manipulation component comprises of the saturation sub-component and the filter sub-component, which are both located within the anti-wind up component.

9. A device as claimed in claim 7, wherein the filter sub-component is a low-pass filter

10. A device as claimed claim 1, wherein the regulator comprises a valve.

11. A device as claimed in claim 10, wherein the valve is a proportional solenoid valve.

12. A device as claimed in claim 1, wherein the drug is a medical gas.

13. A device as claimed in claim 12, wherein the drug is oxygen and the device is for the regulated administration of supplementary oxygen to a patient.

14. A device as claimed in claim 13, wherein at least one sensor is a pulse oximeter, which generates a signal corresponding to the level of oxygen saturation of a patient'"'"'s arterial blood.

15. A device as claimed in claim 1, which comprises a user interface for the setting of a target.

16. A delivery system for regulated administration of a drug to a patient, the system comprising:

a source or reservoir of a drug;

a drug delivery means for the passage of a drug from the source or reservoir to a patient; and

a drug delivery device as defined in claim 1, which is configured such that the regulator is for controllably varying the rate of delivery or dose of drug passing to the patient via the drug delivery means from the source or reservoir.

17. A system as claimed in claim 16, wherein the biochemical, biological or physiological property being measured by the at least one sensor is time-lagged or time delayed with respect to the delivery of drug with which it is associated.

18. A system as claimed in claim 16, wherein the drug is a medical gas.

19. A system as claimed in claim 18, wherein the drug is oxygen and the system is for the regulated administration of supplementary oxygen to a patient.

20. A system as claimed in claim 19, wherein the oxygen source is an oxygen cylinder, dewar or oxygen concentrator.

21. A system as claimed in claim 19, wherein at least one sensor is a pulse oximeter, which generates a signal corresponding to the level of oxygen saturation of the patient'"'"'s blood.

30. A method of administering a drug to a patient comprising the steps of:

providing a source or reservoir of a drug;

providing and fitting to a patient a delivery means for passage of the drug from the reservoir or source to the patient;

providing a device as defined in claim 1 configured to control the passage of the drug form the reservoir or source to the patient via the drug delivery means and fitting the at least one sensor of the device to the patient and configuring said sensor to measure a biochemical, biological or physiological parameter to be influenced by the administration of the drug;

administering a dose or delivery rate of the drug to the patient as regulated by the device; and

causing the controller of the device to control administration of drug to the patient in response to signals generated by the sensor,

whereby the rate of delivery or dosage administered to the patient is such as to provide a controlled influence on the measured biochemical, biological or physiological property as desired.

22-29. -29. (canceled)

31. A method as claimed in claim 30, wherein the drug is oxygen, the sensor is a pulse oximeter and the device has a regulator, which is a valve.

31-36. -36. (canceled)

32. A method as claimed in claim 30, wherein the delivery means comprises tubing connected to an oxygen face mask or nasal cannula.